FI922551A0 - Foerfarande foer skoetsel av septisk chock. - Google Patents

Foerfarande foer skoetsel av septisk chock.

Info

Publication number
FI922551A0
FI922551A0 FI922551A FI922551A FI922551A0 FI 922551 A0 FI922551 A0 FI 922551A0 FI 922551 A FI922551 A FI 922551A FI 922551 A FI922551 A FI 922551A FI 922551 A0 FI922551 A0 FI 922551A0
Authority
FI
Finland
Prior art keywords
skoetsel
septisk
chock
foerfarande foer
antagonist
Prior art date
Application number
FI922551A
Other languages
English (en)
Finnish (fi)
Other versions
FI922551A (fi
Inventor
H Fletcher Starnes
John S Abrams
Original Assignee
Schering Corp
H Fletcher Starnes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, H Fletcher Starnes filed Critical Schering Corp
Publication of FI922551A0 publication Critical patent/FI922551A0/fi
Publication of FI922551A publication Critical patent/FI922551A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Sludge (AREA)
  • Fertilizers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Compression-Type Refrigeration Machines With Reversible Cycles (AREA)
  • Spinning Or Twisting Of Yarns (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI922551A 1989-12-04 1992-06-03 Foerfarande foer skoetsel av septisk chock. FI922551A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44519289A 1989-12-04 1989-12-04
PCT/US1990/006872 WO1991007986A1 (en) 1989-12-04 1990-11-30 Method of treating septic shock

Publications (2)

Publication Number Publication Date
FI922551A0 true FI922551A0 (fi) 1992-06-03
FI922551A FI922551A (fi) 1992-06-03

Family

ID=23767939

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922551A FI922551A (fi) 1989-12-04 1992-06-03 Foerfarande foer skoetsel av septisk chock.

Country Status (11)

Country Link
EP (1) EP0504307B1 (ja)
JP (1) JPH0747547B2 (ja)
AT (1) ATE100331T1 (ja)
AU (1) AU648777B2 (ja)
CA (1) CA2070424A1 (ja)
DE (1) DE69006221T2 (ja)
DK (1) DK0504307T3 (ja)
ES (1) ES2062762T3 (ja)
FI (1) FI922551A (ja)
HU (1) HUT64481A (ja)
WO (1) WO1991007986A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2147466A1 (en) * 1992-10-20 1994-04-28 Just P. J. Brakenhoff Interleukin-6 receptor antagonists
JP3525221B2 (ja) * 1993-02-17 2004-05-10 味の素株式会社 免疫抑制剤
RU2139092C1 (ru) * 1993-06-03 1999-10-10 Терапьютик Антибодиз Инк. Фрагменты антител в терапии
DE4409513C1 (de) * 1994-02-07 1995-10-19 Knoll Ag Verwendung von anti-TNF-Antikörpern als Arzneimittel zur Behandlung von Erkrankungen mit einem erhöhten Interleukin-6 Serumspiegel
US8017121B2 (en) 1994-06-30 2011-09-13 Chugai Seiyaku Kabushika Kaisha Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
CN101361972B (zh) * 1994-10-07 2011-05-25 中外制药株式会社 以il-6拮抗剂作为有效成分治疗慢性类风湿性关节炎
CA2295440A1 (en) * 1997-06-18 1998-12-23 The Rockefeller University Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
US8034344B2 (en) 2008-05-13 2011-10-11 Novimmune S.A. Anti-IL-6/IL-6R antibodies and methods of use thereof
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2598666B2 (ja) * 1987-10-19 1997-04-09 忠三 岸本 抗ヒトｂｃｄｆモノクローナル抗体
CA1341588C (en) * 1988-01-26 2009-01-06 Michel Revel Human ifn-beta2/i1-6, its purification and use
EP0327283B1 (en) * 1988-02-02 1993-08-18 Schering Biotech Corporation Method of reducing immunoglobulin e responses
EP0399429A1 (en) * 1989-05-22 1990-11-28 Toray Industries, Inc. Anti-human interleukin-6 monoclonal antibody

Also Published As

Publication number Publication date
HU9201859D0 (en) 1992-09-28
ES2062762T3 (es) 1994-12-16
WO1991007986A8 (en) 2004-04-22
FI922551A (fi) 1992-06-03
ATE100331T1 (de) 1994-02-15
JPH0747547B2 (ja) 1995-05-24
DE69006221T2 (de) 1994-05-05
DE69006221D1 (de) 1994-03-03
WO1991007986A1 (en) 1991-06-13
EP0504307B1 (en) 1994-01-19
DK0504307T3 (da) 1994-03-21
AU7179491A (en) 1991-06-26
JPH05504058A (ja) 1993-07-01
AU648777B2 (en) 1994-05-05
CA2070424A1 (en) 1991-06-05
HUT64481A (en) 1994-01-28
EP0504307A1 (en) 1992-09-23

Similar Documents

Publication Publication Date Title
UA111707C2 (uk) Застосування виділеного анти-tnf-альфа антитіла людини
MY107079A (en) Method of reducing immunoglobulin e responses
DE3684211D1 (ja)
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
FI922551A0 (fi) Foerfarande foer skoetsel av septisk chock.
EA200400930A1 (ru) Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний
MY107386A (en) Method of preventing or reducing eosinophilia
WO1996040041A3 (en) Antibodies to fas antigen capable of inhibiting apoptosis
FI924278A (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.

Legal Events

Date Code Title Description
FD Application lapsed